| scholarly article | Q13442814 |
| P50 | author | Mohamed Diwan M AbdulHameed | Q57027586 |
| P2093 | author name string | Xueping Yu | |
| Jacob D Feala | |||
| Jaques Reifman | |||
| Bhaskar Dutta | |||
| Chenggang Yu | |||
| Frank Tortella | |||
| Kara Schmid | |||
| Jitendra Dave | |||
| P2860 | cites work | Alzheimer's pathology in human temporal cortex surgically excised after severe brain injury. | Q53264740 |
| Genomic analysis of response to traumatic brain injury in a mouse model of Alzheimer's disease (APPsw). | Q53389533 | ||
| Genetic and histologic evidence implicates role of inflammation in traumatic brain injury-induced apoptosis in the rat cerebral cortex following moderate fluid percussion injury | Q57587950 | ||
| Ability of Minor Elevations of Troponins I and T to Predict Benefit From an Early Invasive Strategy in Patients With Unstable Angina and Non-ST Elevation Myocardial Infarction<SUBTITLE>Results From a Randomized Trial</SUBTITLE> | Q77189918 | ||
| The value of serum tau protein for the diagnosis of intracranial injury in minor head trauma | Q80327699 | ||
| Pathophysiology of traumatic brain injury | Q80487851 | ||
| From proteomics to biomarker discovery in Alzheimer's disease | Q81683823 | ||
| WikiPathways: pathway editing for the people | Q21092742 | ||
| Identification of functional modules using network topology and high-throughput data | Q21202795 | ||
| Towards a proteome-scale map of the human protein–protein interaction network | Q21735930 | ||
| Chronic Traumatic Brain Injury Associated with Boxing | Q22250925 | ||
| Toward an understanding of the protein interaction network of the human liver | Q24292988 | ||
| Systematic analysis of the protein interaction network for the human transcription machinery reveals the identity of the 7SK capping enzyme | Q24321455 | ||
| An empirical framework for binary interactome mapping | Q24322723 | ||
| A human protein-protein interaction network: a resource for annotating the proteome | Q24324450 | ||
| Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles | Q24536351 | ||
| The MicroArray Quality Control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measurements | Q24597089 | ||
| Gene expression profiling of peripheral blood leukocytes identifies and validates ABCB1 as a novel biomarker for Alzheimer's disease. | Q38334380 | ||
| Identifying functional modules in protein-protein interaction networks: an integrated exact approach | Q42646303 | ||
| Conventional and functional proteomics using large format two-dimensional gel electrophoresis 24 hours after controlled cortical impact in postnatal day 17 rats | Q44091909 | ||
| GFAP and S100B are biomarkers of traumatic brain injury: an observational cohort study | Q44243932 | ||
| Transcriptomics of traumatic brain injury: gene expression and molecular pathways of different grades of insult in a rat organotypic hippocampal culture model | Q44990501 | ||
| Biomarkers in the clinical diagnosis and management of traumatic brain injury | Q45061432 | ||
| Hot spots for modulating toxicity identified by genomic phenotyping and localization mapping | Q45094533 | ||
| Identification of plasma biomarkers of TBI outcome using proteomic approaches in an APOE mouse model | Q45352799 | ||
| Comparison of effect sizes associated with biomarkers reported in highly cited individual articles and in subsequent meta-analyses | Q46207178 | ||
| Prevalence and psychological correlates of traumatic brain injury in operation iraqi freedom | Q46707155 | ||
| Effects of head and extracranial injuries on serum protein S100B levels in trauma patients | Q47308109 | ||
| Glial and neuronal proteins in serum predict outcome after severe traumatic brain injury | Q47689828 | ||
| Neuron-specific mRNA complexity responses during hippocampal apoptosis after traumatic brain injury. | Q47880594 | ||
| Gene expression profile changes are commonly modulated across models and species after traumatic brain injury | Q48158143 | ||
| Biomarkers and diagnosis; protein biomarkers in serum of pediatric patients with severe traumatic brain injury identified by ICAT-LC-MS/MS. | Q48293405 | ||
| Serum glial fibrillary acidic protein is a highly specific biomarker for traumatic brain injury in humans compared with S-100B and neuron-specific enolase | Q48336910 | ||
| Novel differential neuroproteomics analysis of traumatic brain injury in rats | Q48487232 | ||
| C-tau biomarker of neuronal damage in severe brain injured patients: association with elevated intracranial pressure and clinical outcome | Q48530314 | ||
| High-density microarray analysis of hippocampal gene expression following experimental brain injury. | Q48663347 | ||
| Tau proteins in serum predict outcome after severe traumatic brain injury | Q48673216 | ||
| Impact of early intervention on outcome after mild traumatic brain injury in children. | Q48697228 | ||
| High serum S100B levels for trauma patients without head injuries | Q48863353 | ||
| Characterization of a new rat model of penetrating ballistic brain injury | Q49039626 | ||
| KEGG for linking genomes to life and the environment | Q24650347 | ||
| High-quality binary protein interaction map of the yeast interactome network | Q24651397 | ||
| Large-scale mapping of human protein-protein interactions by mass spectrometry | Q24670192 | ||
| The human disease network | Q24678240 | ||
| Graph-based iterative Group Analysis enhances microarray interpretation | Q24797743 | ||
| Genomic responses in rat cerebral cortex after traumatic brain injury | Q24816314 | ||
| Probing the extent of randomness in protein interaction networks | Q27337213 | ||
| Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources | Q27860739 | ||
| A comprehensive analysis of protein-protein interactions in Saccharomyces cerevisiae | Q27860755 | ||
| A gene-expression signature as a predictor of survival in breast cancer | Q27860945 | ||
| Network biology: understanding the cell's functional organization | Q27861027 | ||
| A comprehensive two-hybrid analysis to explore the yeast protein interactome | Q27861093 | ||
| An in vivo map of the yeast protein interactome | Q27936680 | ||
| Mass spectrometry-based proteomics | Q28182890 | ||
| Traumatic brain injury--football, warfare, and long-term effects | Q28294364 | ||
| Reactome: a database of reactions, pathways and biological processes | Q28298042 | ||
| Association between Recurrent Concussion and Late-Life Cognitive Impairment in Retired Professional Football Players | Q28315422 | ||
| Network-based analysis of affected biological processes in type 2 diabetes models | Q28469240 | ||
| DEGAS: de novo discovery of dysregulated pathways in human diseases | Q28475850 | ||
| Integration of biological networks and gene expression data using Cytoscape | Q28681323 | ||
| Here is the evidence, now what is the hypothesis? The complementary roles of inductive and hypothesis-driven science in the post-genomic era | Q29398873 | ||
| PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes | Q29547229 | ||
| Comparative assessment of large-scale data sets of protein-protein interactions | Q29547451 | ||
| Drug-target network | Q29614447 | ||
| A gene-coexpression network for global discovery of conserved genetic modules | Q29614451 | ||
| Discovering regulatory and signalling circuits in molecular interaction networks | Q29614951 | ||
| Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer | Q29615523 | ||
| Network-based classification of breast cancer metastasis | Q29616384 | ||
| The genetic association database | Q29617244 | ||
| A new approach to decoding life: systems biology | Q29618876 | ||
| Protein interaction networks from yeast to human | Q30002395 | ||
| BioMart and Bioconductor: a powerful link between biological databases and microarray data analysis | Q30998448 | ||
| The model organism as a system: integrating 'omics' data sets | Q31032864 | ||
| CGI: a new approach for prioritizing genes by combining gene expression and protein-protein interaction data | Q31076352 | ||
| Bioinformatics applications for pathway analysis of microarray data | Q31143279 | ||
| Evidence of probabilistic behaviour in protein interaction networks | Q33317634 | ||
| The blind watchmaker network: scale-freeness and evolution | Q33321257 | ||
| Inferring pathway activity toward precise disease classification | Q33383213 | ||
| A general modular framework for gene set enrichment analysis | Q33405451 | ||
| A novel scoring approach for protein co-purification data reveals high interaction specificity | Q33506600 | ||
| A systems approach to mapping DNA damage response pathways | Q33609206 | ||
| The economic impact of S-100B as a pre-head CT screening test on emergency department management of adult patients with mild traumatic brain injury | Q33657669 | ||
| P43/pro-EMAPII: a potential biomarker for discriminating traumatic versus ischemic brain injury | Q33772594 | ||
| Network-guided analysis of genes with altered somatic copy number and gene expression reveals pathways commonly perturbed in metastatic melanoma | Q33873686 | ||
| Biological interaction networks are conserved at the module level | Q34001171 | ||
| Categorizing biases in high-confidence high-throughput protein-protein interaction data sets | Q34005147 | ||
| Expander: from expression microarrays to networks and functions | Q34097128 | ||
| Glivec (STI571, imatinib), a rationally developed, targeted anticancer drug | Q34139151 | ||
| Human traumatic brain injury alters plasma microRNA levels. | Q34140925 | ||
| αII-spectrin breakdown products (SBDPs): diagnosis and outcome in severe traumatic brain injury patients | Q34142573 | ||
| Neuroprotection for traumatic brain injury: translational challenges and emerging therapeutic strategies | Q34147023 | ||
| Inferring high-confidence human protein-protein interactions | Q34257665 | ||
| Blood-based diagnostics of traumatic brain injuries | Q34714369 | ||
| Benchmarking yeast two-hybrid systems using the interactions of bacterial motility proteins | Q35008242 | ||
| Biokinetic analysis of ubiquitin C-terminal hydrolase-L1 (UCH-L1) in severe traumatic brain injury patient biofluids | Q35040539 | ||
| Metabolic labeling of RNA uncovers principles of RNA production and degradation dynamics in mammalian cells | Q35044194 | ||
| Promising strategies to minimize secondary brain injury after head trauma | Q35052446 | ||
| Metabolic pathways in the post-genome era. | Q35135595 | ||
| Building with a scaffold: emerging strategies for high- to low-level cellular modeling | Q35146255 | ||
| Impact of early intervention on outcome following mild head injury in adults | Q35468756 | ||
| Neuronal and glial markers are differently associated with computed tomography findings and outcome in patients with severe traumatic brain injury: a case control study | Q35558386 | ||
| GENECODIS: a web-based tool for finding significant concurrent annotations in gene lists | Q35724720 | ||
| Clinical utility of serum levels of ubiquitin C-terminal hydrolase as a biomarker for severe traumatic brain injury. | Q35783757 | ||
| Glial neuronal ratio: a novel index for differentiating injury type in patients with severe traumatic brain injury | Q35886747 | ||
| Ubiquitin C-terminal hydrolase is a novel biomarker in humans for severe traumatic brain injury | Q36242794 | ||
| Experimental models of traumatic brain injury: do we really need to build a better mousetrap? | Q36293845 | ||
| Modeling cellular machinery through biological network comparison | Q36443509 | ||
| PathNet: a tool for pathway analysis using topological information | Q36585204 | ||
| High‐capacity peptide‐centric platform to decode the proteomic response to brain injury | Q36683737 | ||
| Axonal mRNA in uninjured and regenerating cortical mammalian axons | Q36784476 | ||
| Reliability of S100B in predicting severity of central nervous system injury | Q36830747 | ||
| Protein networks in disease | Q37125547 | ||
| Accuracy of mild traumatic brain injury diagnosis | Q37206028 | ||
| Strategies for discovering novel cancer biomarkers through utilization of emerging technologies | Q37241749 | ||
| GeneCodis: interpreting gene lists through enrichment analysis and integration of diverse biological information | Q37245619 | ||
| Detection of protein biomarkers using high-throughput immunoblotting following focal ischemic or penetrating ballistic-like brain injuries in rats | Q37249448 | ||
| Elevated levels of serum glial fibrillary acidic protein breakdown products in mild and moderate traumatic brain injury are associated with intracranial lesions and neurosurgical intervention | Q37316677 | ||
| A novel signaling pathway impact analysis. | Q37319638 | ||
| Deciphering complex mechanisms in neurodegenerative diseases: the advent of systems biology | Q37366016 | ||
| Biomarkers for the diagnosis, prognosis, and evaluation of treatment efficacy for traumatic brain injury. | Q37374156 | ||
| Applying mass spectrometry-based proteomics to genetics, genomics and network biology | Q37581410 | ||
| Can low serum levels of S100B predict normal CT findings after minor head injury in adults?: an evidence-based review and meta-analysis | Q37770871 | ||
| Molecular and physiological responses to juvenile traumatic brain injury: focus on growth and metabolism | Q37808919 | ||
| Neuroproteomics and systems biology-based discovery of protein biomarkers for traumatic brain injury and clinical validation | Q37817168 | ||
| c-Abl in Neurodegenerative Disease | Q37897502 | ||
| P433 | issue | 13 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | traumatic brain injury | Q1995526 |
| systems biology | Q815297 | ||
| biomarker | Q864574 | ||
| brain | Q1073 | ||
| P304 | page(s) | 1101-1116 | |
| P577 | publication date | 2013-07-01 | |
| P1433 | published in | Journal of Neurotrauma | Q15716774 |
| P1476 | title | Systems biology approaches for discovering biomarkers for traumatic brain injury | |
| P478 | volume | 30 |
| Q52721984 | A Critical Evaluation of Wet Biomarkers for Huntington's Disease: Current Status and Ways Forward |
| Q42377448 | A strategy for evaluating pathway analysis methods. |
| Q35008896 | A systems biology strategy to identify molecular mechanisms of action and protein indicators of traumatic brain injury |
| Q39413072 | Application of Systems Biology to Neuroproteomics: The Path to Enhanced Theranostics in Traumatic Brain Injury. |
| Q38743997 | Applying Systems Biology Methodology To Identify Genetic Factors Possibly Associated with Recovery after Traumatic Brain Injury |
| Q62496796 | Big Data in traumatic brain injury; promise and challenges |
| Q35635041 | Chapter 6 state of the science of pediatric traumatic brain injury: biomarkers and gene association studies. |
| Q28543001 | Characterization of chemically induced liver injuries using gene co-expression modules |
| Q90268782 | Chemogenomics Systems Pharmacology Mapping of Potential Drug Targets for Treatment of Traumatic Brain Injury |
| Q41598901 | Current and Emerging Technologies for Probing Molecular Signatures of Traumatic Brain Injury |
| Q37076892 | Differential Neuroproteomic and Systems Biology Analysis of Spinal Cord Injury |
| Q28822270 | Mining kidney toxicogenomic data by using gene co-expression modules |
| Q38190877 | Molecular biomarkers of epileptogenesis |
| Q35229002 | Multivariate analysis of traumatic brain injury: development of an assessment score. |
| Q33753230 | On the crucial cerebellar wound healing-related pathways and their cross-talks after traumatic brain injury in Danio rerio |
| Q39413066 | Role of Systems Biology in Brain Injury Biomarker Discovery: Neuroproteomics Application |
| Q48217863 | S100B and Glial Fibrillary Acidic Protein as Indexes to Monitor Damage Severity in an In Vitro Model of Traumatic Brain Injury. |
| Q58091096 | Scaled traumatic brain injury results in unique metabolomic signatures between gray matter, white matter, and serum in a piglet model |
| Q28544814 | Systems level analysis and identification of pathways and networks associated with liver fibrosis |
| Q39173777 | The Application of Proteomics to Traumatic Brain and Spinal Cord Injuries |
| Q30000283 | Uncovering precision phenotype-biomarker associations in traumatic brain injury using topological data analysis |
| Q30959630 | What's New in Traumatic Brain Injury: Update on Tracking, Monitoring and Treatment |
| Q47286955 | iTRAQ-Based Quantitative Proteomics Reveals the New Evidence Base for Traumatic Brain Injury Treated with Targeted Temperature Management |
Search more.